Calamos Advisors LLC Novo Nordisk A S Transaction History

Calamos Advisors LLC

$16.1 Billion
Q3 2024

A detailed history of Calamos Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Calamos Advisors LLC holds 220,619 shares of NVO stock, worth $22.8 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

220,619

Previous 304,343 27.51%

Holding current value

$22.8 Million

Previous $43.4 Million 39.53%

% of portfolio

0.16%

Previous 0.28%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$119.07 - $145.42 $9.97 Million - $12.2 Million	-83,724 Reduced 27.51%	220,619 $26.3 Million
Q2 2024 Jul 25, 2024	SELL	$122.71 - $146.91 $490,594 - $587,346	-3,998 Reduced 1.3%	304,343 $43.4 Million
Q1 2024 May 08, 2024	SELL	$102.11 - $135.92 $1.57 Million - $2.09 Million	-15,413 Reduced 4.76%	308,341 $39.6 Million
Q4 2023 Jan 31, 2024	SELL	$87.78 - $105.45 $753,503 - $905,182	-8,584 Reduced 2.58%	323,754 $33.5 Million
Q3 2023 Oct 25, 2023	BUY	$90.94 - $199.54 $15.1 Million - $33.1 Million	165,928 Added 99.71%	332,338 $30.2 Million
Q2 2023 Jul 28, 2023	SELL	$155.98 - $172.65 $4.65 Million - $5.14 Million	-29,780 Reduced 15.18%	166,410 $26.9 Million
Q1 2023 May 03, 2023	SELL	$132.34 - $159.14 $4.49 Million - $5.4 Million	-33,931 Reduced 14.74%	196,190 $31.2 Million
Q4 2022 Jan 25, 2023	SELL	$102.55 - $135.33 $3.08 Million - $4.07 Million	-30,066 Reduced 11.56%	230,121 $0
Q3 2022 Oct 24, 2022	SELL	$95.28 - $116.93 $791,395 - $971,220	-8,306 Reduced 3.09%	260,187 $25.9 Million
Q2 2022 Aug 01, 2022	BUY	$103.24 - $121.81 $4.3 Million - $5.07 Million	41,627 Added 18.35%	268,493 $29.9 Million
Q1 2022 May 03, 2022	SELL	$93.1 - $112.54 $128,850 - $155,755	-1,384 Reduced 0.61%	226,866 $25.2 Million
Q4 2021 Feb 01, 2022	BUY	$95.88 - $117.08 $1.01 Million - $1.23 Million	10,536 Added 4.84%	228,250 $25.6 Million
Q3 2021 Oct 26, 2021	BUY	$84.42 - $106.62 $215,017 - $271,561	2,547 Added 1.18%	217,714 $20.9 Million
Q2 2021 Jul 22, 2021	BUY	$67.66 - $84.76 $2.82 Million - $3.53 Million	41,686 Added 24.03%	215,167 $18 Million
Q1 2021 Apr 12, 2021	SELL	$67.06 - $75.82 $6.15 Million - $6.95 Million	-91,699 Reduced 34.58%	173,481 $11.7 Million
Q4 2020 Jan 27, 2021	SELL	$63.89 - $73.8 $7.11 Million - $8.21 Million	-111,287 Reduced 29.56%	265,180 $18.5 Million
Q3 2020 Oct 26, 2020	BUY	$63.69 - $70.22 $1.9 Million - $2.09 Million	29,804 Added 8.6%	376,467 $26.1 Million
Q2 2020 Jul 27, 2020	BUY	$58.54 - $67.94 $5.63 Million - $6.53 Million	96,159 Added 38.39%	346,663 $22.7 Million
Q1 2020 Apr 28, 2020	BUY	$49.46 - $64.78 $11 Million - $14.5 Million	223,404 Added 824.37%	250,504 $15.1 Million
Q4 2019 Jan 15, 2020	BUY	$49.86 - $58.26 $334,062 - $390,342	6,700 Added 32.84%	27,100 $1.57 Million
Q1 2019 Apr 12, 2019	BUY	$46.36 - $52.63 $945,744 - $1.07 Million	20,400 New	20,400 $1.07 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $233B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Account

Calamos Advisors LLC Novo Nordisk A S Transaction History